Cybin (HELP) Consolidated Net Income (2020 - 2022)
Cybin (HELP) posted Consolidated Net Income of $4.6 million for Q2 2022, up 186.82% on a QoQ basis from -$5.2 million in Q1 2021.
Cybin (HELP) Consolidated Net Income (2020 - 2022) Analysis & Trends
Cybin's Consolidated Net Income history runs 3 years deep, the most recent figure standing at $4.6 million for Q2 2022.
- Quarterly Consolidated Net Income changed N/A year-over-year to $4.6 million in Q2 2022, while the trailing twelve-month figure through Mar 2026 was -$0.0 (changed 0.0% YoY) and the FY2026 annual result came in at -$147.8 million, down 74.01% from the prior year.
- Consolidated Net Income was $4.6 million for Q2 2022 at Cybin, up from -$5.2 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $144.2 million in Q2 2020 and bottomed at -$162.1 million in Q4 2020.
- A 3-year average of -$3.7 million and a median of -$1921.8 in 2020 frame the typical range for Consolidated Net Income.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Cybin | 262.76 Mn | 262.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2022 | 4.55 Mn |
| Mar 31, 2021 | -5.24 Mn |
| Dec 31, 2020 | -162.13 Mn |
| Sep 30, 2020 | -1,921.84 |
| Jun 30, 2020 | 144.24 Mn |